Showing results (1171-1180 of 1,426) with videos related to

Sort By:
Pageof 143
ACS Applied Materials & Interfaces|July 8, 2020
Nanopatterned Titanium Implants Accelerate Bone Formation In VivoAndrew I M Greer, Vitali Goriainov, Janos Kanczler, et al.
American Heart Journal|December 3, 2014
How can we optimize the processes of care for acute coronary syndromes to improve outcomes?Lars Wallentin, Steen Dalby Kristensen, Jeffrey L Anderson, et al.
Journal of the American College of Cardiology|December 21, 2019
Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT TrialAnthony H Gershlick, Amerjeet S Banning, Emma Parker, et al.
Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.
Journal of Thrombosis and Haemostasis : JTH|February 26, 2025
Plasmin cleavage of β2-glycoprotein I alters its structure and ability to bind to pathogenic antibodiesHannah F Bradford, Christophe J Lalaurie, Jayesh Gor, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Unleashing the Potential of 1,3-Diketone Analogues as Selective LH2 InhibitorsJuhoon Lee, Hou-Fu Guo, Shike Wang, et al.
Molecular Cancer Therapeutics|August 17, 2022
Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and AutophagyMilad Soleimani, Alexander Somma, Tamer Kaoud, et al.
Bioorganic Chemistry|November 6, 2018
Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanomaAshraf A Aly, Essmat M El-Sheref, Momtaz E M Bakheet, et al.
Biomaterials|November 4, 2025
Synthetic peptide hydrogels as a model of the bone marrow niche demonstrate efficacy of a combined CRISPR-CAR T-cell therapy for acute myeloid leukaemiaW Sebastian Doherty-Boyd, P Monica Tsimbouri, Vineetha Jayawarna, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 20, 2020
Impact of Early (≤24 h) Versus Delayed (>24 h) Intervention in Patients With Non-ST Segment Elevation Myocardial Infarction: An Observational Study of 20,882 Patients From the London Heart Attack GroupVasileios Panoulas, Krishnaraj S Rathod, Ajay K Jain, et al.
Pageof 143